Broomwell to use the Reka E100L device and related monitoring service
To serve UK’s private market and Britain’s National Health Service network
BRITISH electrocardiogram (ECG) interpretation service Broomwell-Healthwatch Ltd has deployed Singapore-based Reka Health Pte Ltd cardiac monitors and cloud-based solutions.
The solutions will be used to serve both the National Health Service (NHS) primary care and private market in the United Kingdom to detect arrhythmia, Reka said in a statement.
Broomwell, whose cardiac-physiologists have successfully interpreted over 500,000 ECGs, currently offers mobile ECG recorder units for patients to wear 24 hours a day for up to eight days.
Broomwell is now expanding its arrhythmia detection offerings to include the E100L Digital Loop Event Monitor by Reka.
Episodes of arrhythmia, a heart condition whereby the heartbeat is irregular, can occur anytime, lasting anywhere between a few minutes to a few hours, Reka said.
The Digital Loop Event Monitor service is a seven-day home monitoring service, offered by Broomwell, to record the ECG of a patient that is experiencing arrhythmia.
“Our arrhythmia monitoring will be greatly enhanced by the ease of use and efficient transmission of data, inherent in the Reka system,” said Broomwell chairman Joshua Rowe.
“Reka’s solution enables immediate analysis and interpretation of results by Broomwell’s expert cardiac clinicians,” he added.
The Reka E100L (pic) can record valuable ECG data before and after an arrhythmia episode experienced by a patient. The data will be uploaded to Reka’s cloud solution, providing cardiac-physiologists with insights into what triggered each episode.
The device, which can fit into a pocket giving users mobility outside the hospital, allows users to quickly record an episode anywhere, when necessary, Reka said.
Supported by Reka’s facility in the Netherlands, Broomwell is deploying the solution to enhance the operational efficiency of its cardiac professionals.
Patients can also use a computer or mobile application to upload ECG recordings, which can be immediately interpreted with the aid of online records.
“With Reka’s solution being deployed to serve the NHS market, our E100L can benefit more heart patients in the United Kingdom while reducing the healthcare cost burden,” said Reka chief executive officer Tan Kae Yuan (pic).
Reka was founded in 2011, and is headquartered in Singapore with satellite offices in New Jersey, the United States and the Netherlands.
Its digital cardiovascular monitoring solution comprises medical grade devices, computer and mobile software, and cloud-based web applications that are seamlessly integrated.
iGene conquers UK, eyes Middle East and US next
‘Wearable’ artificial kidney wins innovation award in Singapore
How mobility can be a game-changer for healthcare
Startup with rehab robot aims for next level with crowdfunding drive
Diabetes device start-up seeks crowd-funding boost
For more technology news and the latest updates, follow us on Twitter, LinkedIn or Like us on Facebook.